# US 2014/0371481 A1 · Synthesis of free radical polymerizable ethylenically unsaturated poloxamers and poloxamines

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0371481 A1
- Document ID: US20140371481A1
- Status: Published application
- Kind: A1
- Application number: 14/308,229
- Filed: 2014-06-18
- Published: 2014-12-18
- Earliest claimed: 2013-06-18
- Assignees: Bausch & Lomb Incorporated
- Applicants: Bausch & Lomb Incorporated
- Inventors: Alok Kumar Awasthi; Jay F. Kunzler; Ganugapati Satyanarayana; Satheesha Rai Nooji
- Web page: https://patentgrep.com/patent/US20140371481A1

## CPC

- C08F 290/062: {Polyethers}
- C08G 65/3322: {acyclic}
- C08G 65/337: containing other elements (organic compounds containing halogens only as halides of a carboxyl group C08G65/332)
- C08G 65/48: Polymers modified by chemical after-treatment
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

A new synthetic method of forming free radical polymerizable end terminal functionalized poloxamers and poloxamines in commercial scale batches which uses a binary system of inhibitors to eliminate the formation of high molecular weight impurities. It has also been surprisingly discovered that the inorganic impurities formed during the commercial scale synthetic process are removed by the use of resin materials.

## Claims

### Claim 1

A method comprising reacting a poloxamer or poloxamine compound with a first methacrylating agent in the presence of a solvent stabilized with a first free radical inhibitor to form a first reaction product, and further reacting the first reaction product with an organic base and a second methacrylating agent stabilized with a second free radical inhibitor to form a second reaction product, wherein the first free radical inhibitor is a different compound than the second free radical inhibitor.

### Claim 2 (depends on 1)

The method of claim 1 wherein the first and second methacrylating agents are the same.

### Claim 3 (depends on 2)

The method of claim 2 wherein the methacrylating agent is methacryloyl chloride.

### Claim 4 (depends on 3)

The method of claim 3 wherein the first free radical inhibitor is 2,6 di tert-butyl-4-methyl phenol (BHT).

### Claim 5 (depends on 4)

The method of claim 4 wherein the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ).

### Claim 6 (depends on 5)

The method of claim 5 wherein the organic base is triethylamine (TEA).

### Claim 7 (depends on 1)

The method of claim 1 wherein the first free radical inhibitor is 2,6 ditert-butyl-4-methyl phenol (BHT).

### Claim 8 (depends on 7)

The method of claim 7 wherein the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ).

### Claim 9 (depends on 1)

The method of claim 1 wherein the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ).

### Claim 10 (depends on 1)

The method of claim 1 wherein the organic base is triethylamine (TEA).

### Claim 11 (depends on 1)

The method of claim 1 wherein the poloxamer or poloxamine compound is a poloxamer compound, wherein the first reaction product is a monomethacrylated poloxamer compound and wherein the second reaction product is a dimethacrylated poloxamer compound.

### Claim 12 (depends on 1)

The method of claim 1 wherein the first and second methacrylating agents are methacryloyl chloride, the first free radical inhibitor is 2,6 di tert-butyl-4-methyl phenol (BHT), and the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ).

### Claim 13 (depends on 12)

The method of claim 12 wherein the organic base is triethylamine (TEA).

### Claim 14 (depends on 13)

The method of claim 13 wherein the poloxamer compound is reacted with the first methacrylating agent in the presence of the organic base.

### Claim 15 (depends on 1)

The method of claim 1 wherein the poloxamer or poloxamine compound is a poloxamine compound, wherein the first reaction product is a monomethacrylated poloxamine compound and wherein the second reaction product is a polymethacrylated poloxamine compound.

### Claim 16 (depends on 15)

The method of claim 15 wherein the first and second methacrylating agents are methacryloyl chloride, the first free radical inhibitor is 2,6 di tert-butyl-4-methyl phenol (BHT), and the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ).

### Claim 17 (depends on 16)

The method of claim 16 wherein the organic base is triethylamine (TEA).

### Claim 18 (depends on 17)

The method of claim 17 wherein the poloxamine compound is reacted with the first methacrylating agent in the presence of the organic base.

### Claim 19 (depends on 1)

The method of claim 1 wherein the poloxamer or poloxamine compound is reacted with the first methacrylating agent in the presence of the organic base.
